clinical-nursing-pediatrics-2018-keynote

2 / 12

Page 8
Notes:
allied
academies
Current Pediatric Research| Volume: 22
November 28-29, 2018 | Dubai, UAE
15th World Congress on
Pediatrics, Clinical Pediatrics and Nutrition
28th International Conference on
Nursing Practice
Joint Event
&
NSC-631570 is the very first proton anticancer preparation
and due to this after administration it accumulates in
tumors very fast that can be seen under the UVlight thanks to its
the autofluorescence. Besides this preparation can regenerate
the immune system and works as a immunomodulating agent.
The selective effect of the NSC 631570 has been confirmed by
120 universities and research centers in the world. Until now
this preparation has been tested on over 100 cancer cell lines
and on 12 normal cell lines.
The researchers who conducted studies with the anti-cancer
preparation NSC-631570 concluded: “The anticancer drug NSC-
631570 exerts its cytotoxic effects on both mouse and human
breast cancer cell lines in a dose and time dependent manner.
Weeks following NSC-631570 treatment, cells maintained a
reduced capacity to proliferate.”
In a controlled clinical study conducted at the University
Grodno (Grodno, Belarus), after the therapy with NSC-631570
the hardening of the tumor, a slight increase in the tumor size
(5-10%) and proliferation of connective tissues were observed.
The tumours appeared harder and slightly enlarged after NSC-
631570 therapy, and were easier to detect by ultrasound or
radiological examination. Metastatic lymph nodes were also
hardened and sclerotic (fibrous). Tumours and metastatic
lymph nodes were clearly demarcated from healthy tissue and
therefore easier to remove. Complications such as prolonged
lymphorrhoea (leakage of lymph onto the skin surface), skin
necrosis (death of skin tissue), suppuration of the wound, and
pneumonia, all occurred in patients from the two NSC-631570
groups at only half the rate that they appeared in patients
from the control group. Based on the results of this study the
scientists from Grodno recommended the use of NSC-631570,
at the higher dosage, in all breast cancer
operations. Other parameters were also evaluated, e.g.
hormones (T3, T4, cortisol, progesterone, estradiol, prolactin),
immune values (lymphocytes, immune globulins, complement,
phagocytic activity, morphologic and cytochemical changes),
amino acids and their derivates in plasma and in the tumor
tissue.
The effect of the NSC-631570 on the various parameters in
breast cancer patients have been studied. Best results were
achieved with higher dosage of NSC-631570. Almost every
patient noted the improvement of the general wellbeing, sleep
and appetite. During the surgery, the tumors as well as involved
lymph nodes were presented sclerotic and well demarcated
from the surrounding tissue. This alleviated the surgical removal
of the tumor considerably. In the tumor tissue, increased
concentration of the amino acid proline was revealed indicating
augmented production of connective tissue that demarcates
the tumor from surrounding tissue. NSC-631570 improved also
the amino acid balance of patients.
Speaker Biography
Wassil Nowicky, Director of “Nowicky Pharma” and President of the Ukrainian Anti-
Cancer Institute (Vienna, Austria). Has finished his study at the Radiotechnical Faculty
of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to
“Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. Inventor
of the anticancer preparation on basis of celandine alkaloids “NSC-631570”. Author of
over 300 scientific articles dedicated to cancer research. Real member of the New York
Academy of Sciences, member of the European Union for applied immunology and of the
American Association for scientific progress, honorary doctor of the Janka Kupala University
in Hrodno, doctor “honoris causa” of the Open international university on complex
medicine in Colombo, honorary member of the Austrian Society of a name of Albert
Schweizer. Received the award for merits of National guild of pharmacists of America,
the award of Austrian Society of sanitary, hygiene and public health services and others.
e:
Wassil Nowicky
Ukrainian Anti-Cancer Institute, Austria
Anti-Cancer preparation NSC-631570 (Ukrain) and its efficacy in the treatment of
Cancer patients
Wassil Nowicky, Pediatrics and Clinical Pediatrics 2018
& Nursing Practice 2018, Volume 22
DOI: 10.4066/0971-9032-C2-004